PB 16 of 2022

 

National Health (IVF Program) Special Arrangement Amendment Instrument 2022 (No. 1)

 

National Health Act 1953

___________________________________________________________________________

 

I, DAVID LAFFAN, Assistant Secretary, Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 100(2) of the National Health Act 1953.

Dated 28th February 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DAVID LAFFAN

Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division


 

___________________________________________________________________________

1               Name of Instrument

(1)           This instrument is the National Health (IVF Program) Special Arrangement Amendment Instrument 2022 (No. 1).

(2)           This instrument may also be cited as PB 16 of 2022.

2               Commencement

(1)           Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 March 2022

1 March 2022

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)           Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3               Authority

This instrument is made under subsection 100(2) of the National Health Act 1953.

4               Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

 

Schedule 1  Amendments

National Health (IVF Program) Special Arrangement 2015 (PB 60 of 2015)

[1]           Part 1, Section 4, definition for ‘Regulations’

substitute:

Regulations means the National Health (Pharmaceutical Benefits) Regulations 2017

[2]           Schedule 1, entry for Chorionic gonadotrophin

substitute:

Chorionic gonadotrophin

Injection set containing powder for injection 1,500 units, 3 and solvent 1 mL, 3

Injection

Pregnyl

C(100)

 

Injection set containing powder for injection 1,500 units, 3 and solvent 1 mL, 3 (s19A)

Injection

Brevactid 1500 I.E

C(100)

 

Powder for injection 5,000 units with solvent

Injection

Pregnyl

PB(100)

 

Powder for injection 5,000 units with solvent (s19A)

Injection

Choriomon 5000 I.E

PB(100)